Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
4-O-Methyl honokiol
Cat. No.:
0225LY-0927
Appearance:
Liquid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
4-O-Methyl honokiol is a magnolia-derived lignan and PPARγ agonist with neuroprotective, anti-inflammatory, and anti-cancer properties; it is used in oncology research for its ability to inhibit NF-κB activity.
Synonym:
4-O-Methylhonokiol; 68592-15-4; 4-methoxyhonokiol; 4'-O-Methylhonokiol; 2-(4-methoxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol; 4'-Methoxy-3',5-di-2-propen-1-yl[1,1'-biphenyl]-2-ol; [1,1'-Biphenyl]-2-ol, 4'-methoxy-3',5-di-2-propenyl-; (1,1'-Biphenyl)-2-ol, 4'-methoxy-3',5-di-2-propenyl-
CAS No.:
68592-15-4
Compound CID:
155160
Formula:
C19H20O2
Formula Weight:
280.36
Specification
Relative Density:
1.054 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
4-O-Methyl honokiol can be used in neuropharmacology to investigate its potential anti-inflammatory and memory-enhancing biological activities.
Library Information
Target:
NF-κB; PPAR
Receptor:
PPARγ; NF-κB
Pathways:
DNA damage/DNA repair; Metabolism; NF-κB
Plate Number:
AOCL-12
Plate Location:
h8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
80 mg/mL; 285.35 mM
